New cancer drug targets stomach and pancreatic tumors in early trial
Disease control
Ongoing
This early-stage study is testing a new drug called ASKB589 in people with advanced solid tumors that have spread or cannot be removed by surgery. The main goals are to find a safe dose, see how the body processes the drug, and check if it can shrink tumors, especially in stomach…
Phase: PHASE1, PHASE2 • Sponsor: Jiangsu Aosaikang Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC